EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Enzymes in riboflavin biosynthesis: Potential antibiotic drug targets

Juthamas Jaroensuk, Litavadee Chuaboon, Chatchai Kesornpun, Pimchai Chaiyen

Archives of Biochemistry and Biophysics · 2023

DOI: 10.1016/j.abb.2023.109762 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archives of Biochemistry and Biophysics, 2023. Verfasst von Juthamas Jaroensuk und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomolecular Science and Engineering, Vidyasirimedhi Institute of Science and Technology (VISTEC), Wangchan Valley, Wangchan, Rayong, 21210…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Riboswitch. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 106 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rapid resistance of pathogens to antibiotics has emerged as a major threat to global health. Identification of new antibiotic targets is thus needed for developing alternative drugs. Genes encoding enzymes involved in the biosynthesis of riboflavin and flavin cofactors (FMN/FAD) are attractive targets because these enzymatic reactions are necessary for most bacteria to synthesize flavin cofactors for use in their central metabolic reactions. Moreover, humans lack most of these enzymes because we uptake riboflavin from our diet. This review discusses the current knowledge of enzymes involved in bacterial biosynthesis of riboflavin and other flavin cofactors, as well as the functions of the FMN riboswitch. Here, we highlight recent progress in the structural and mechanistic characterization, and inhibition of GTP cyclohydrolase II (GCH II), lumazine synthase (LS), riboflavin synthase (RFS), FAD synthetase (FADS), and FMN riboswitch, which have been identified as plausible antibiotic targets. As the structures and functions of these enzymes and regulatory systems are not completely understood, they are attractive as subjects for future in-depth biochemical and biophysical analysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsRiboswitchHumansFlavin MononucleotideRiboflavinFlavin-Adenine Dinucleotide

Substanzen

Anti-Bacterial AgentsFlavin MononucleotideRiboswitchRiboflavinFlavin-Adenine Dinucleotide

Autor:innen und Institutionen

  • School of Biomolecular Science and Engineering, Vidyasirimedhi Institute of Science and Technology (VISTEC), Wangchan Valley, Wangchan, Rayong, 21210, Thailand.
  • School of Pharmacy and Biomass and Oil Palm Center of Excellence, Walailak University, Nakhon Si Thammarat, 80160, Thailand.
  • School of Biomolecular Science and Engineering, Vidyasirimedhi Institute of Science and Technology (VISTEC), Wangchan Valley, Wangchan, Rayong, 21210, Thailand. Electronic address: pimchai.chaiyen@vistec.ac.th.

Zitieren

APA

Jaroensuk, J., Chuaboon, L., Kesornpun, C., & Chaiyen, P. (2023). Enzymes in riboflavin biosynthesis: Potential antibiotic drug targets. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2023.109762

Vancouver

Jaroensuk J, Chuaboon L, Kesornpun C, Chaiyen P. Enzymes in riboflavin biosynthesis: Potential antibiotic drug targets. Archives of Biochemistry and Biophysics. 2023. doi:10.1016/j.abb.2023.109762

BibTeX
@article{Jaroensuk2023,
  author = {Jaroensuk, Juthamas and Chuaboon, Litavadee and Kesornpun, Chatchai and Chaiyen, Pimchai},
  title = {Enzymes in riboflavin biosynthesis: Potential antibiotic drug targets},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2023},
  doi = {10.1016/j.abb.2023.109762}
}
Kostenlos starten →